Sinobioway Medicine
0025813.423.64% ( +0.12 )
Q1 2026 Earnings
Financial report interval: 2025.12.31 - 2026.03.31
Overview: Sinobioway Medicine(002581) the Revenue is 43.86 M (+24.15%);the EBIT is -41.68 M (+5.93%);the EPS is -0.0822 (-47.05%).
Actual
YoY
Estimate
YoY
Vs estimate
YoY
Revenue
0.04B24.15%
----
----
EBIT
-0.04B5.93%
----
----
EPS
-0.082247.05%
----
----
Revenue
ActualEstimateUnit: CNY
qf
EBIT
ActualEstimateUnit: CNY
qf
Net income
ActualEstimateUnit: CNY
qf
EPS
ActualEstimateUnit: CNY
qf